Health
AI-based method used to screen for Alzheimer’s disease drugs – Drug Target Review
Researchers have used artificial intelligence to screen 80 FDA-approved drugs and reveal which could be used as Alzheimer’s treatments.
Posted: 5 March 2021 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have used artificial intelligence to screen 80 FDA-approved drugs and reveal which could be used as Alzheimer’s treatments.
A team at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS), both US, has developed an artificial intelligence (AI)-based method to screen currently available medications as possible treatments for Alzheimer’s disease.
According to the researchers, the method could represent…
Continue Reading
